CVS

insider transactions

CVS HEALTH Corp — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 90d

-3.8M

0 buy · 3.8M sell

Net value · 90d

-$359.0M

$0 in · $359.0M out

Sentiment · 90d

Net selling

0% buying · 100% selling

Open-market trades · 90d

0 buy · 3.8M sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Other·F
May 31, 26

Brian Newman KEY

EVP, Chief Financial Officer

$225.4K

2.5K sh · $90.98

Own -45%
Other·F
May 31, 26

Amy Compton-Phillips

EVP, Chief Medical Officer

$693.1K

7.6K sh · $90.98

Own -44%
Sell·S
May 21, 26

Larry Robbins

Director

$35.3M

378.0K sh · $93.31

Own -100%
Sell·S
May 21, 26

Larry Robbins

Director

$34.6M

370.5K sh · $93.45

Own -7%
Other·D
May 21, 26

Fernando Aguirre

Director

$146.1K

1.6K sh · $93.50

Own -13%
Sell·S
May 20, 26

Larry Robbins

Director

$77.0K

800 sh · $96.28

Own -0%
Sell·S
May 20, 26

Larry Robbins

Director

$6.4M

66.9K sh · $95.67

Own -1%
Sell·S
May 20, 26

Larry Robbins

Director

$14.5M

152.7K sh · $94.81

Own -3%
Sell·S
May 20, 26

Larry Robbins

Director

$74.6M

797.6K sh · $93.48

Own -13%
Other·D
May 20, 26

Fernando Aguirre

Director

$2.9M

30.4K sh · $93.78

Own -72%
Sell·S
May 19, 26

Larry Robbins

Director

$14.4K

151 sh · $95.18

Own -0%
Sell·S
May 19, 26

Larry Robbins

Director

$187.3M

2.0M sh · $94.45

Own -24%
Grant·A
May 15, 26

Fernando Aguirre

Director

$999

14 sh · $71.38

Own +0%
Grant·A
May 14, 26

John E Gallina

Director

$140.6K

1.4K sh · $97.15

Own New
Grant·A
May 14, 26

Michael F Mahoney

Director

$168.8K

1.7K sh · $97.15

Own +37%
Grant·A
May 14, 26

Scott J Kirby

Director

$140.6K

1.4K sh · $97.15

Own +11%
Grant·A
May 14, 26

Leslie V Norwalk

Director

$140.6K

1.4K sh · $97.15

Own +24%
Grant·A
May 14, 26

Guy P Sansone

Director

$140.6K

1.4K sh · $97.15

Own +11%
Grant·A
May 14, 26

DECOUDREAUX ALECIA A

Director

$140.6K

1.4K sh · $97.15

Own +4%
Grant·A
May 14, 26

Anne A. Finucane

Director

$150.0K

1.5K sh · $97.15

Own +9%
Grant·A
May 14, 26

Douglas H. Shulman

Director

$140.6K

1.4K sh · $97.15

Own New
Grant·A
May 14, 26

Larry Robbins

Director

$187.5K

1.9K sh · $97.15

Own +23%
Grant·A
May 14, 26

Jeffrey R. Balser

Director

$199.9K

2.1K sh · $97.15

Own +15%
Grant·A
May 14, 26

David C Brown II

Director

$150.0K

1.5K sh · $97.15

Own +1%
Grant·A
May 14, 26

Fernando Aguirre

Director

$151.8K

1.6K sh · $97.15

Own +4%
Sell·S
May 8, 26

Tilak Mandadi

EVP, Chief Exp & Tech Officer

$6.2M

69.6K sh · $89.58

Own -87%
Other·F
Apr 1, 26

Prem S Shah KEY

EVP and Group President

$107.6K

1.5K sh · $72.49

Own -2%
Other·F
Apr 1, 26

Steven H Nelson KEY

EVP and President, Aetna

$176.3K

2.4K sh · $72.49

Own -46%
Other·F
Apr 1, 26

Tilak Mandadi

EVP, Chief Exp & Tech Officer

$263.4K

3.6K sh · $72.49

Own -4%
Other·F
Apr 1, 26

Samrat S. Khichi

EVP, CPO and General Counsel

$256.7K

3.5K sh · $72.49

Own -10%
Other·F
Apr 1, 26

David J. Joyner KEY

President, CEO and Chair

$582.0K

8.0K sh · $72.49

Own -10%
Other·F
Apr 1, 26

James David Clark

SVP, Cont & Chief Acct Officer

$236.5K

3.3K sh · $72.49

Own -17%
Other·F
Apr 1, 26

Heidi B Capozzi

EVP and Chief People Officer

$96.7K

1.3K sh · $72.49

Own -9%
Grant·A
Mar 31, 26

Prem S Shah KEY

EVP and Group President

$11.6M

161.7K sh · $71.82

Own New
Grant·A
Mar 31, 26

Prem S Shah KEY

EVP and Group President

$1.8M

25.1K sh · $71.82

Own +66%
Grant·A
Mar 31, 26

Brian Newman KEY

EVP, Chief Financial Officer

$9.0M

125.7K sh · $71.82

Own New
Grant·A
Mar 31, 26

Brian Newman KEY

EVP, Chief Financial Officer

$1.4M

19.5K sh · $71.82

Own +89%
Grant·A
Mar 31, 26

Steven H Nelson KEY

EVP and President, Aetna

$10.3M

143.7K sh · $71.82

Own New
Grant·A
Mar 31, 26

Steven H Nelson KEY

EVP and President, Aetna

$1.6M

22.3K sh · $71.82

Own +104%
Grant·A
Mar 31, 26

Tilak Mandadi

EVP, Chief Exp & Tech Officer

$10.3M

143.7K sh · $71.82

Own New
Grant·A
Mar 31, 26

Tilak Mandadi

EVP, Chief Exp & Tech Officer

$1.6M

22.3K sh · $71.82

Own +34%
Grant·A
Mar 31, 26

Samrat S. Khichi

EVP, CPO and General Counsel

$5.8M

80.8K sh · $71.82

Own New
Grant·A
Mar 31, 26

Samrat S. Khichi

EVP, CPO and General Counsel

$900.0K

12.5K sh · $71.82

Own +49%
Grant·A
Mar 31, 26

David J. Joyner KEY

President, CEO and Chair

$6.2M

86.3K sh · $71.82

Own +116%
Grant·A
Mar 31, 26

Amy Compton-Phillips

EVP, Chief Medical Officer

$2.6M

35.9K sh · $71.82

Own New
Grant·A
Mar 31, 26

Amy Compton-Phillips

EVP, Chief Medical Officer

$400.0K

5.6K sh · $71.82

Own +10%
Grant·A
Mar 31, 26

James David Clark

SVP, Cont & Chief Acct Officer

$860.1K

12.0K sh · $71.82

Own New
Grant·A
Mar 31, 26

James David Clark

SVP, Cont & Chief Acct Officer

$799.9K

11.1K sh · $71.82

Own +46%
Grant·A
Mar 31, 26

Heidi B Capozzi

EVP and Chief People Officer

$4.6M

64.7K sh · $71.82

Own New
Grant·A
Mar 31, 26

Heidi B Capozzi

EVP and Chief People Officer

$720.0K

10.0K sh · $71.82

Own +13%
Grant·A
Mar 31, 26

Fernando Aguirre

Director

$60.1K

883 sh · $68.02

Own +3%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
May 31, 2026	Brian Newman KEY	EVP, Chief Financial Officer	Other F	2.5K	-45%	$90.98	$225.4K
May 31, 2026	Amy Compton-Phillips	EVP, Chief Medical Officer	Other F	7.6K	-44%	$90.98	$693.1K
May 21, 2026	Larry Robbins	Director	Sell S	378.0K	-100%	$93.31	$35.3M
May 21, 2026	Larry Robbins	Director	Sell S	370.5K	-7%	$93.45	$34.6M
May 21, 2026	Fernando Aguirre	Director	Other D	1.6K	-13%	$93.50	$146.1K
May 20, 2026	Larry Robbins	Director	Sell S	800	-0%	$96.28	$77.0K
May 20, 2026	Larry Robbins	Director	Sell S	66.9K	-1%	$95.67	$6.4M
May 20, 2026	Larry Robbins	Director	Sell S	152.7K	-3%	$94.81	$14.5M
May 20, 2026	Larry Robbins	Director	Sell S	797.6K	-13%	$93.48	$74.6M
May 20, 2026	Fernando Aguirre	Director	Other D	30.4K	-72%	$93.78	$2.9M
May 19, 2026	Larry Robbins	Director	Sell S	151	-0%	$95.18	$14.4K
May 19, 2026	Larry Robbins	Director	Sell S	2.0M	-24%	$94.45	$187.3M
May 15, 2026	Fernando Aguirre	Director	Grant A	14	+0%	$71.38	$999
May 14, 2026	John E Gallina	Director	Grant A	1.4K	New	$97.15	$140.6K
May 14, 2026	Michael F Mahoney	Director	Grant A	1.7K	+37%	$97.15	$168.8K
May 14, 2026	Scott J Kirby	Director	Grant A	1.4K	+11%	$97.15	$140.6K
May 14, 2026	Leslie V Norwalk	Director	Grant A	1.4K	+24%	$97.15	$140.6K
May 14, 2026	Guy P Sansone	Director	Grant A	1.4K	+11%	$97.15	$140.6K
May 14, 2026	DECOUDREAUX ALECIA A	Director	Grant A	1.4K	+4%	$97.15	$140.6K
May 14, 2026	Anne A. Finucane	Director	Grant A	1.5K	+9%	$97.15	$150.0K
May 14, 2026	Douglas H. Shulman	Director	Grant A	1.4K	New	$97.15	$140.6K
May 14, 2026	Larry Robbins	Director	Grant A	1.9K	+23%	$97.15	$187.5K
May 14, 2026	Jeffrey R. Balser	Director	Grant A	2.1K	+15%	$97.15	$199.9K
May 14, 2026	David C Brown II	Director	Grant A	1.5K	+1%	$97.15	$150.0K
May 14, 2026	Fernando Aguirre	Director	Grant A	1.6K	+4%	$97.15	$151.8K
May 8, 2026	Tilak Mandadi	EVP, Chief Exp & Tech Officer	Sell S	69.6K	-87%	$89.58	$6.2M
Apr 1, 2026	Prem S Shah KEY	EVP and Group President	Other F	1.5K	-2%	$72.49	$107.6K
Apr 1, 2026	Steven H Nelson KEY	EVP and President, Aetna	Other F	2.4K	-46%	$72.49	$176.3K
Apr 1, 2026	Tilak Mandadi	EVP, Chief Exp & Tech Officer	Other F	3.6K	-4%	$72.49	$263.4K
Apr 1, 2026	Samrat S. Khichi	EVP, CPO and General Counsel	Other F	3.5K	-10%	$72.49	$256.7K
Apr 1, 2026	David J. Joyner KEY	President, CEO and Chair	Other F	8.0K	-10%	$72.49	$582.0K
Apr 1, 2026	James David Clark	SVP, Cont & Chief Acct Officer	Other F	3.3K	-17%	$72.49	$236.5K
Apr 1, 2026	Heidi B Capozzi	EVP and Chief People Officer	Other F	1.3K	-9%	$72.49	$96.7K
Mar 31, 2026	Prem S Shah KEY	EVP and Group President	Grant A	161.7K	New	$71.82	$11.6M
Mar 31, 2026	Prem S Shah KEY	EVP and Group President	Grant A	25.1K	+66%	$71.82	$1.8M
Mar 31, 2026	Brian Newman KEY	EVP, Chief Financial Officer	Grant A	125.7K	New	$71.82	$9.0M
Mar 31, 2026	Brian Newman KEY	EVP, Chief Financial Officer	Grant A	19.5K	+89%	$71.82	$1.4M
Mar 31, 2026	Steven H Nelson KEY	EVP and President, Aetna	Grant A	143.7K	New	$71.82	$10.3M
Mar 31, 2026	Steven H Nelson KEY	EVP and President, Aetna	Grant A	22.3K	+104%	$71.82	$1.6M
Mar 31, 2026	Tilak Mandadi	EVP, Chief Exp & Tech Officer	Grant A	143.7K	New	$71.82	$10.3M
Mar 31, 2026	Tilak Mandadi	EVP, Chief Exp & Tech Officer	Grant A	22.3K	+34%	$71.82	$1.6M
Mar 31, 2026	Samrat S. Khichi	EVP, CPO and General Counsel	Grant A	80.8K	New	$71.82	$5.8M
Mar 31, 2026	Samrat S. Khichi	EVP, CPO and General Counsel	Grant A	12.5K	+49%	$71.82	$900.0K
Mar 31, 2026	David J. Joyner KEY	President, CEO and Chair	Grant A	86.3K	+116%	$71.82	$6.2M
Mar 31, 2026	Amy Compton-Phillips	EVP, Chief Medical Officer	Grant A	35.9K	New	$71.82	$2.6M
Mar 31, 2026	Amy Compton-Phillips	EVP, Chief Medical Officer	Grant A	5.6K	+10%	$71.82	$400.0K
Mar 31, 2026	James David Clark	SVP, Cont & Chief Acct Officer	Grant A	12.0K	New	$71.82	$860.1K
Mar 31, 2026	James David Clark	SVP, Cont & Chief Acct Officer	Grant A	11.1K	+46%	$71.82	$799.9K
Mar 31, 2026	Heidi B Capozzi	EVP and Chief People Officer	Grant A	64.7K	New	$71.82	$4.6M
Mar 31, 2026	Heidi B Capozzi	EVP and Chief People Officer	Grant A	10.0K	+13%	$71.82	$720.0K
Mar 31, 2026	Fernando Aguirre	Director	Grant A	883	+3%	$68.02	$60.1K

About CVS insider trading

This page tracks insider transactions for CVS HEALTH Corp (CVS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.